These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8583766)

  • 1. Mast cell tumour destruction in dogs by hypotonic solution.
    Grier RL; Di Guardo G; Myers R; Merkley DF
    J Small Anim Pract; 1995 Sep; 36(9):385-8. PubMed ID: 8583766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell tumor destruction by deionized water.
    Grier RL; Di Guardo G; Schaffer CB; Pedrosa B; Myers R; Merkley DF; Thouvenelle M
    Am J Vet Res; 1990 Jul; 51(7):1116-20. PubMed ID: 2117868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: a randomized, double-blind, placebo-controlled study.
    Brocks BA; Neyens IJ; Teske E; Kirpensteijn J
    Vet Surg; 2008 Jul; 37(5):472-8. PubMed ID: 18986315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
    Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
    J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs.
    Simpson AM; Ludwig LL; Newman SJ; Bergman PJ; Hottinger HA; Patnaik AK
    J Am Vet Med Assoc; 2004 Jan; 224(2):236-40. PubMed ID: 14736068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    Kiupel M; Webster JD; Miller RA; Kaneene JB
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumours.
    Jaffe MH; Hosgood G; Kerwin SC; Hedlund CS; Taylor HW
    J Small Anim Pract; 2000 Jan; 41(1):7-11. PubMed ID: 10713976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of surgical margins utilized for removal of cutaneous mast cell tumors in dogs.
    Selmic LE; Ruple A
    BMC Vet Res; 2020 Jan; 16(1):5. PubMed ID: 31906934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
    Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL
    J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
    Stanclift RM; Gilson SD
    J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection.
    Murphy S; Sparkes AH; Smith KC; Blunden AS; Brearley MJ
    Vet Rec; 2004 Jun; 154(24):743-6. PubMed ID: 15224593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
    Weisse C; Shofer FS; Sorenmo K
    J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
    Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
    J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
    Séguin B; Leibman NF; Bregazzi VS; Ogilvie GK; Powers BE; Dernell WS; Fettman MJ; Withrow SJ
    J Am Vet Med Assoc; 2001 Apr; 218(7):1120-3. PubMed ID: 11318363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
    Chaffin K; Thrall DE
    Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
    Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
    J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy for incompletely resected canine mast cell tumors.
    LaDue T; Price GS; Dodge R; Page RL; Thrall DE
    Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine mast cell tumors.
    Hess PW
    Vet Clin North Am; 1977 Feb; 7(1):133-43. PubMed ID: 403650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.